Notably, our data firstly showed that cisplatin treatment led to a decrease of circ-ABCB10 in lung cancer cells, indicating the involvement of circ-ABCB10 in the cellular response to cisplatin in lung cancer. Here, ABCB10 is linked to lung carcinoma.